GlassScriptPhysician profile
Yun-Beom Choi
NPI 1194773192
$1,560.25
in general payments reported to CMS, 2019-2025
17 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $70.47 · 2021: $69.72 · 2022: $383 · 2023: $170 · 2024: $346 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Education: $34.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.61 |
| Education | $34.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.68 | 2019-2025 | Qulipta |
| Emd Serono, INC. | $459.37 | 2019-2024 | Mavenclad |
| Eisai INC. | $137.24 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $82.95 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $62.10 | 2024-2025 | Dysport |
| Ge Healthcare | $44.60 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $41.22 | 2019 | |
| Alexion Pharmaceuticals, INC. | $34.12 | 2023 | Ultomiris |
| Pfizer INC. | $32.52 | 2023-2024 | |
| Octapharma USA, INC. | $25.91 | 2022 | |
| Abbott Laboratories | $23.01 | 2019 | |
| Life Molecular Imaging LTD | $16.87 | 2024 | Neuraceq |
| Janssen Pharmaceuticals, INC | $15.00 | 2022 | |
| Upsher-Smith Laboratories LLC | $14.98 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.21 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.20 | 2019 | |
| Biogen, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yun-Beom Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.